Although our study did not evaluate PD-L1 expression, findings from other sarcoma studies suggest that CD8+ T cells may exert their effects independently, underscoring their critical role in tumor immune dynamics and therapeutic responsiveness [33,34,35]. Here, CD8A is linked to sarcoma.